Actively Recruiting
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
Led by University Hospital, Montpellier · Updated on 2026-03-13
25
Participants Needed
1
Research Sites
197 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.
CONDITIONS
Official Title
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant woman
- Singleton pregnancy
- Pregnancy between 7 and 16 weeks of amenorrhea (WA)
- Woman 63; 18 years
- Woman who has signed an informed consent
- Woman affiliated to social security or equivalent scheme
You will not qualify if you...
- Person under guardianship or curatorship
- Person placed under legal protection
- Person unable to provide the participant with informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Montpellier
Montpellier, France, France, 34295
Actively Recruiting
Research Team
V
Vincent GATINOIS, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here